Cardiology

COVID-19 vaccination is associated with a transient increase in cardiovascular risks, but complete vaccination significantly reduces the risk of more severe cardiovascular events.

Adults with epilepsy face double the risk of cardiovascular events, with enzyme-inducing antiseizure medications contributing significantly to this increased risk.

The venous excess ultrasound score improves mortality prediction in acute heart failure patients, offering a better assessment of venous congestion than traditional methods.

A study reveals a J-shaped link between mean heart rate and 30-day mortality in older ICU patients with sepsis. The lowest risk was observed for heart rates between 73 and 82 bpm,

Neurologic events following TAVR are linked to worse survival outcomes. Research highlights that strokes pose the greatest mortality risk.

The ESC 2024 TIGHT-K trial found that relaxed potassium control is just as effective as tight control for preventing atrial fibrillation post-CABG surgery.

A single-pill with four blood pressure drugs is more effective than a three-drug combo for resistant hypertension, per ESC Congress 2024.

ESC 2024: The SHAM-PVI trial confirms that catheter ablation significantly reduces atrial fibrillation burden and improves quality of life compared to a sham treatment.